REQUEST A DEMO
Total
USD $0.00
Search more companies

Refarm Kimya Laboratuvari A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Refarm Kimya Laboratuvari Sanayi Ve Ticaret Anonim Sirketi Profile Updated: August 01, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English Download a sample report

Refarm Kimya Laboratuvari A.S. is an enterprise based in Turkiye. Its main office is in Istanbul. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on September 17, 1985. There are currently 15 (2024) people employed by Refarm Kimya Laboratuvari A.S.. The company’s latest financial report indicates a net sales revenue increase of 26.57% in 2020. A growth of 40.2% was recorded in its total assets. The net profit margin of Refarm Kimya Laboratuvari A.S. increased by 5.06% in 2020.

Headquarters
Elmadag No:48 Inonu Mahallesi Cimen Sokak Sisli
Istanbul; Marmara; Postal Code: 34373

Contact Details: Purchase the Refarm Kimya Laboratuvari A.S. report to view the information.

Website: http://www.refarm.com.tr

Basic Information
Total Employees:
Purchase the Refarm Kimya Laboratuvari A.S. report to view the information.
Outstanding Shares:
Purchase the Refarm Kimya Laboratuvari A.S. report to view the information.
Incorporation Date:
September 17, 1985
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Refarm Kimya Laboratuvari A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
26.57%
Total operating revenue
26.57%
Operating profit (EBIT)
198.36%
Net Profit (Loss) for the Period
441.68%
Total assets
40.2%
Total equity
39.04%
Operating Profit Margin (ROS)
6.54%
Net Profit Margin
5.06%
Return on Equity (ROE)
20.87%
Debt to Equity Ratio
1.23%
Quick Ratio
-0.53%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?